Literature DB >> 8322908

Thrombin and bradykinin initiate discrete endothelial solute permeability mechanisms.

R C Schaeffer1, F Gong, M S Bitrick, T L Smith.   

Abstract

This study documents the discrete solute permeability mechanisms associated with physiologically high concentrations of human alpha-thrombin and bradykinin stimulation of bovine pulmonary artery endothelial cell (BPAEC) monolayers using fluorescein isothiocyanate-hydroxyethyl starch macromolecules. Agonist-induced alterations of intracellular free calcium ([Ca2+]i) using fura-2 acetoxymethyl ester were also measured. BPAEC monolayers showed restricted diffusion consistent with a small-pore (approximately 150 A) radius under baseline conditions. Thrombin produced a major increase in monolayer permeability that was greatest for solute molecular radii (ae) > 100 A. This effect was associated with the exposure of the large (approximately 2,000 A) pores of the filter support by 50- to 1,050-microns2 open areas between approximately 0.5% of the adjacent endothelial cells. This heterogeneous endothelial barrier of parallel large- and small-pore transport pathways permitted solute convection with free diffusion across a few large pores to dominate the restricted diffusion of most apparently unperturbed endothelial junctions. Bradykinin produced a small, transient elevation in monolayer permeability to ae < 35 A, consistent with an increase in the number of small pores or a decrease in path length of this transport pathway. The bradykinin- and thrombin-induced peak elevations in [Ca2+]i were inversely associated with the degree of increased monolayer solute permeability, and enzymatically inhibited thrombin produced none of these effects. These data show that bradykinin and human alpha-thrombin represent two distinct classes of endothelial cell agonists that initiate discrete solute permeability mechanisms.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8322908     DOI: 10.1152/ajpheart.1993.264.6.H1798

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  20 in total

1.  Inhibition of kinin breakdown prolongs retention and action of bradykinin in a myocardial B2 receptor compartment.

Authors:  Andreas Dendorfer; Verena Folkers; Matthias Klinger; Sebastian Wolfrum; Peter Dominiak
Journal:  Br J Pharmacol       Date:  2003-01       Impact factor: 8.739

2.  Activation of blood coagulation in chronic urticaria: pathophysiological and clinical implications. [corrected]

Authors:  Marco Cicardi
Journal:  Intern Emerg Med       Date:  2010-03-27       Impact factor: 3.397

3.  Micromechanical architecture of the endothelial cell cortex.

Authors:  Devrim Pesen; Jan H Hoh
Journal:  Biophys J       Date:  2004-10-15       Impact factor: 4.033

Review 4.  Activation of blood coagulation in chronic urticaria: pathophysiological and clinical implications.

Authors:  Massimo Cugno; Angelo V Marzano; Riccardo Asero; Alberto Tedeschi
Journal:  Intern Emerg Med       Date:  2009-12-01       Impact factor: 3.397

5.  Ca(2+)-inhibitable adenylyl cyclase modulates pulmonary artery endothelial cell cAMP content and barrier function.

Authors:  T Stevens; Y Nakahashi; D N Cornfield; I F McMurtry; D M Cooper; D M Rodman
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

6.  Features of Antihistamine-Resistant Chronic Urticaria and Chronic Urticaria During Exacerbation.

Authors:  Zhu Huilan; Liang Bihua; Li Runxiang; Li Jiayan; Lin Luyang; Li Zhenjie
Journal:  Indian J Dermatol       Date:  2015 May-Jun       Impact factor: 1.494

7.  Bradykinin and alpha-thrombin increase human umbilical vein endothelial macromolecular permeability by different mechanisms.

Authors:  W D Ehringer; O L Wang; A Haq; F N Miller
Journal:  Inflammation       Date:  2000-04       Impact factor: 4.092

Review 8.  Mechanisms of action that contribute to efficacy of omalizumab in chronic spontaneous urticaria.

Authors:  A P Kaplan; A M Giménez-Arnau; S S Saini
Journal:  Allergy       Date:  2017-01-04       Impact factor: 13.146

9.  Bradykinin antagonizes the effects of alpha-thrombin.

Authors:  W D Ehringer; M J Edwards; R D Gray; F N Miller
Journal:  Inflammation       Date:  1997-06       Impact factor: 4.092

10.  Carbazochrome sodium sulfonate (AC-17) reverses endothelial barrier dysfunction through inhibition of phosphatidylinositol hydrolysis in cultured porcine endothelial cells.

Authors:  Toshiaki Sendo; Yoshinori Itoh; Keisei Aki; Michiko Oka; Ryozo Oishi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-08-20       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.